Stryker's Suppliers recorded an increase in sales by 4.29 % year on year in Q3 2026, from the previous quarter, sales fell by -0.11 %, Stryker recorded an increase in cost of sales by 3.04 % year on year, sequentially cost of sales grew by 8.66 % in Q3.
Stryker's Suppliers recorded an increase in sales by 4.29 % year on year in Q3 2026, from the previous quarter, sales fell by -0.11 %, Stryker recorded increase in cost of sales by 3.04 % year on year, sequentially cost of sales grew by 8.66 % in Q3.
Raw materials essential to the business are generally available from multiple sources; however, certain raw materials are currently sourced from single suppliers. Most manufactured products are stocked in inventory, while some MedSurg products are assembled to order.
Stryker's Comment on Supply Chain
Raw materials essential to the business are generally available from multiple sources; however, certain raw materials are currently sourced from single suppliers. Most manufactured products are stocked in inventory, while some MedSurg products are assembled to order.
SYK's Suppliers Net Income grew by
SYK's Suppliers Net margin grew in Q3 to
33.54 %
8.55 %
SYK's Suppliers Net Income grew by 33.54 %
SYK's Suppliers Net margin grew in Q3 to 8.55 %
Stryker's Suppliers Sales Growth
in Q3 2026 by Industry
Sources:
Stryker Corp's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Stryker Corp’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
4.29 %